A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors
Michael A. Samuels(Banner MD Anderson Cancer Center), Esther G.C. Troost(Helmholtz-Zentrum Dresden-Rossendorf)
International Journal of Radiation Oncology*Biology*Physics
September 24, 2023
Cited by 62
Related Papers
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology
|Radiotherapy and Oncology|2021|69